These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 31126020)

  • 21. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
    Yin Y; Zhang M; Dorfman RG; Li Y; Zhao Z; Pan Y; Zhou Q; Huang S; Zhao S; Yao Y; Zou X
    Cell Death Dis; 2017 Jun; 8(6):e2856. PubMed ID: 28569784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Proapoptotic Peptide Targeting Interleukin-4 Receptor.
    Permpoon U; Khan F; Vadevoo SMP; Gurung S; Gunassekaran GR; Kim MJ; Kim SH; Thuwajit P; Lee B
    Mol Pharm; 2020 Nov; 17(11):4077-4088. PubMed ID: 32881535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-Derived Organoids of Cholangiocarcinoma.
    Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
    Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
    Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein.
    Saikawa S; Kaji K; Nishimura N; Seki K; Sato S; Nakanishi K; Kitagawa K; Kawaratani H; Kitade M; Moriya K; Namisaki T; Mitoro A; Yoshiji H
    Cancer Lett; 2018 Oct; 434():120-129. PubMed ID: 30031758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer effects of the combined Thai noni juice ethanolic extracts and 5-fluorouracil against cholangiocarcinoma cells in vitro and in vivo.
    Prompipak J; Senawong T; Sripa B; Ketterman AJ; Utaiwat S; Woranam K; Jeeunngoi J; Senawong G
    Sci Rep; 2021 Jul; 11(1):14866. PubMed ID: 34290264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
    Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
    Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
    Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
    Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand.
    Saensa-Ard S; Leuangwattanawanit S; Senggunprai L; Namwat N; Kongpetch S; Chamgramol Y; Loilome W; Khansaard W; Jusakul A; Prawan A; Pairojkul C; Khantikeo N; Yongvanit P; Kukongviriyapan V
    Tumour Biol; 2017 Nov; 39(11):1010428317725925. PubMed ID: 29110582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Aminolevulinic acid-mediated photodynamic activity in patient-derived cholangiocarcinoma organoids.
    Fujiwara H; Takahara N; Tateishi K; Tanaka M; Kanai S; Kato H; Nakatsuka T; Yamamoto K; Kogure H; Arita J; Nakai Y; Kasuga M; Ushiku T; Hasegawa K; Koike K
    Surg Oncol; 2020 Dec; 35():484-490. PubMed ID: 33126085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study.
    Li S; Han Z; Ma Y; Song R; Pei T; Zheng T; Wang J; Xu D; Fang X; Jiang H; Liu L
    Oncol Rep; 2014 Jan; 31(1):145-52. PubMed ID: 24247752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
    Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
    Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.
    Hernandez MC; Bergquist JR; Leiting JL; Ivanics T; Yang L; Smoot RL; Nagorney DM; Truty MJ
    J Gastrointest Surg; 2019 Apr; 23(4):818-824. PubMed ID: 30756315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
    Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
    Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma.
    Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W
    Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification.
    Hu B; Li H; Guo W; Sun YF; Zhang X; Tang WG; Yang LX; Xu Y; Tang XY; Ding GH; Qiu SJ; Zhou J; Li YX; Fan J; Yang XR
    Int J Cancer; 2020 Mar; 146(6):1606-1617. PubMed ID: 31310010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma.
    Garcia PL; Miller AL; Gamblin TL; Council LN; Christein JD; Arnoletti JP; Heslin MJ; Reddy S; Richardson JH; Cui X; van Waardenburg RCAM; Bradner JE; Yang ES; Yoon KJ
    Mol Cancer Ther; 2018 Jan; 17(1):107-118. PubMed ID: 29142067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo.
    Hisaka T; Yano H; Ogasawara S; Momosaki S; Nishida N; Takemoto Y; Kojiro S; Katafuchi Y; Kojiro M
    J Hepatol; 2004 Nov; 41(5):782-9. PubMed ID: 15519651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
    Di Matteo S; Nevi L; Costantini D; Overi D; Carpino G; Safarikia S; Giulitti F; Napoletano C; Manzi E; De Rose AM; Melandro F; Bragazzi M; Berloco PB; Giuliante F; Grazi G; Giorgi A; Cardinale V; Adorini L; Gaudio E; Alvaro D
    PLoS One; 2019; 14(1):e0210077. PubMed ID: 30677052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.